Review Article Open Access March 30, 2024

Essence Control of Active Pharmaceutical Ingredients

1
New Jersey, United States
Page(s): 23-29
Received
January 08, 2024
Revised
February 12, 2024
Accepted
March 22, 2024
Published
March 30, 2024
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright: Copyright © The Author(s), 2024. Published by Scientific Publications
Article metrics
Views
937
Downloads
75

Cite This Article

APA Style
Adak, S. (2024). Essence Control of Active Pharmaceutical Ingredients. Current Research in Public Health, 4(1), 23-29. https://doi.org/10.31586/wjcmr.2024.1020
ACS Style
Adak, S. Essence Control of Active Pharmaceutical Ingredients. Current Research in Public Health 2024 4(1), 23-29. https://doi.org/10.31586/wjcmr.2024.1020
Chicago/Turabian Style
Adak, Sourav. 2024. "Essence Control of Active Pharmaceutical Ingredients". Current Research in Public Health 4, no. 1: 23-29. https://doi.org/10.31586/wjcmr.2024.1020
AMA Style
Adak S. Essence Control of Active Pharmaceutical Ingredients. Current Research in Public Health. 2024; 4(1):23-29. https://doi.org/10.31586/wjcmr.2024.1020
@Article{crph1020,
AUTHOR = {Adak, Sourav},
TITLE = {Essence Control of Active Pharmaceutical Ingredients},
JOURNAL = {Current Research in Public Health},
VOLUME = {4},
YEAR = {2024},
NUMBER = {1},
PAGES = {23-29},
URL = {https://www.scipublications.com/journal/index.php/WJCMR/article/view/1020},
ISSN = {2831-5162},
DOI = {10.31586/wjcmr.2024.1020},
ABSTRACT = {Active Pharmaceutical Ingredients (APIs) form the backbone of pharmaceutical formulations, influencing their efficacy, safety, and stability. Essence control of APIs involves stringent regulation and optimization of their chemical, physical, and biological properties to ensure consistent quality and therapeutic outcomes. This manuscript explores the critical aspects of essence control in APIs, including synthesis, characterization, quality assessment, and regulatory considerations. The synthesis of Active Pharmaceutical Ingredients is a pivotal stage in pharmaceutical manufacturing, where precise control over chemical reactions and process conditions is paramount to achieving high-quality, safe, and effective medicines. Advances in synthetic methodologies, optimization strategies, sustainability practices, and the implementation of PAT technologies continue to drive innovation in API synthesis, supporting the development of novel therapeutic agents and enhancing pharmaceutical manufacturing efficiency.},
}
%0 Journal Article
%A Adak, Sourav
%D 2024
%J Current Research in Public Health

%@ 2831-5162
%V 4
%N 1
%P 23-29

%T Essence Control of Active Pharmaceutical Ingredients
%M doi:10.31586/wjcmr.2024.1020
%U https://www.scipublications.com/journal/index.php/WJCMR/article/view/1020
TY  - JOUR
AU  - Adak, Sourav
TI  - Essence Control of Active Pharmaceutical Ingredients
T2  - Current Research in Public Health
PY  - 2024
VL  - 4
IS  - 1
SN  - 2831-5162
SP  - 23
EP  - 29
UR  - https://www.scipublications.com/journal/index.php/WJCMR/article/view/1020
AB  - Active Pharmaceutical Ingredients (APIs) form the backbone of pharmaceutical formulations, influencing their efficacy, safety, and stability. Essence control of APIs involves stringent regulation and optimization of their chemical, physical, and biological properties to ensure consistent quality and therapeutic outcomes. This manuscript explores the critical aspects of essence control in APIs, including synthesis, characterization, quality assessment, and regulatory considerations. The synthesis of Active Pharmaceutical Ingredients is a pivotal stage in pharmaceutical manufacturing, where precise control over chemical reactions and process conditions is paramount to achieving high-quality, safe, and effective medicines. Advances in synthetic methodologies, optimization strategies, sustainability practices, and the implementation of PAT technologies continue to drive innovation in API synthesis, supporting the development of novel therapeutic agents and enhancing pharmaceutical manufacturing efficiency.
DO  - Essence Control of Active Pharmaceutical Ingredients
TI  - 10.31586/wjcmr.2024.1020
ER  -